Intelligence · Patents

Patents expiring in 2026

Annual patent cliff calendar for 2026 — US pharmaceutical patents by expiration date.

Patents
360

Quick answer

360 indexed pharmaceutical patents have expiration dates in 2026. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 7097841

    Ferritin fusion proteins for use in vaccines and other applications

    New Century Pharmaceuticals, Inc. · Granted Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 7098345

    Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-YL)methyl]-4H-carbazol-4-one

    TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 7098330

    Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 7098364

    Phenylethanolamine compounds as β2-receptor agonists, and methods of use and preparation thereof

    Jinzhou Jiutai Pharmaceutical Co., Ltd., China · Granted Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 7098306

    Method and compositions for treating hepatocellular cancer

    The Regents of the University of California · Granted Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 7098197

    Phosphonate compounds

    The Regents of the University of California · Granted Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 7098191

    Hyperthermic inducible expression vectors for gene therapy and methods of use thereof

    THE ARIZONA BOARD OF REGENTS · Granted Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 7098025

    Human peroxisome proliferator activated receptor gamma (pparγ) gene regulatory sequences and uses therefor

    Ligand Pharmaceuticals Incorporated · Granted Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 7097998

    Aβ42 lowering agents

    The Regents of the University of California · Granted Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 7097972

    Method and composition for regulating apoptosis

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 7097991

    Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof

    The Regents of the University of California · Granted Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 7097856

    Dendrimeric support or carrier macromolecule

    The Regents of the University of California · Granted Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 7102059

    DNA molecules and polypeptides of Pseudomonas syringae Hrp pathogenicity island and their uses

    The Board of Regents University Community College System of Nevada on Behalf of the University of Nevada-Las Vegas · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 7101557

    Combined tissue factor methods for coagulation and tumor treatment

    The Board of Regents of the University of Texas System · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 7101846

    Methods and compositions for optimization of oxygen transport by cell-free systems

    The Regents of the University of California · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 7101909

    Calcium channel drugs and uses

    Theravance, Inc. · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. US 7101867

    Benzofuran derivatives, their production and use

    Takeda Pharmaceutical Company Limited · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. US 7101548

    Functional role of adrenomedullin (AM) and the gene-related product (PAMP) in human pathology and physiology

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. US 7101899

    5-pyridyl-1,3-azole compounds, process for producing the same and use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 7101547

    Method for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance P by using anti-substance P antibodies

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  21. US 7101932

    Method for the preparation of 1-benzotriazolyl carbonate esters of poly (ethylene glycol)

    Nektar Therapeutics AL, Corporation · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  22. US 7101863

    Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative

    BIODEX · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  23. US 7101852

    Composition and method for treatment and prevention of restenosis

    The Board of Regents of the University of Texas System · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  24. US 7101541

    Utilization of non-viral sequences for minus-strand DNA transfer and gene reconstitution

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  25. US 7101964

    Intermediate for preparing glycopeptide derivatives

    Theravance, Inc. · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  26. US 7105514

    Substituted indolealkanoic acids

    The Institute for Dibetes Discovery LLC · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  27. US 7105169

    Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  28. US 7105641

    MCP-1 receptor antibodies

    The Regents of the University of California · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  29. US 7105546

    Acyclic and cyclic amine derivatives

    Vertex Pharmaceuticals Incorporated · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  30. US 7105183

    Chlorite in the treatment of neurodegenerative disease

    The Regents of the University of California · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  31. US 7105156

    Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cells

    The Regents of the University of California · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  32. US 7105695

    Synthesis of combretastatin A-2 prodrugs

    ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  33. US 7105643

    Monoclonal antibodies specific for crack cocaine metabolites, a cell line producing the same, and crack cocaine conjugates

    The United States of America as represented by the Attorney General of the Dept. of Justice · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  34. US 7105572

    Stable emulsion compositions

    Takeda Pharmaceutical Company Limited · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  35. US 7105558

    Gastrin and cholecystokinin receptor lignads (iv)

    The James Black Foundation Limited · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  36. US 7105561

    Use of etodolac for the treatment of prostate cancer

    The Regents of the University of California · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  37. US 7105560

    Use of etodolac in the treatment of multiple myeloma

    The Regents of the University of California · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  38. US 7105496

    Methods and compositions for inhibiting angiogenesis

    Northwestern University · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  39. US 7105488

    G protein-coupled receptor antagonists

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  40. US 7105171

    Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia

    The Regents of the University of California · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  41. US 7105170

    Latent human tuberculosis model, diagnostic antigens, and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  42. US 7105330

    Human plasma hyaluronidase

    The Regents of the University of California · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  43. US 7109188

    Methods and compositions for treating atheroma, tumors and other neoplastic tissue

    The Board of Regents of the University of Texas System · Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  44. US 7108975

    Atlastin

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  45. US 7109245

    Vasoconstrictor cannabinoid analogs

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  46. US 7108986

    Glypican-1 in human breast cancer

    The Regents of the University of California · Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  47. US 7109215

    Compounds possessing neuronal activity

    Vertex Pharmaceuticals Incorporated · Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  48. US 7109303

    Modified cytokines for use in cancer therapy

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2026?

360 published patents in our USPTO index have expiration dates falling in calendar year 2026.